omeprazole has been researched along with Esophageal Stricture in 40 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Omeprazole reduced the risk of short-term developing esophageal strictures following grade 2b and 3a corrosive esophageal injuries." | 9.41 | A prospective randomized controlled trial of omeprazole for preventing esophageal stricture in grade 2b and 3a corrosive esophageal injuries. ( Awsakulsutthi, S; Boochangkool, N; Havanond, C; Mahawongkajit, P; Mingmalairak, C; Tomtitchong, P, 2021) |
| "Better control of gastric acid secretion with omeprazole appeared to decrease the need for dilatation of oesophageal strictures complicating gastro-oesophageal reflux disease in our hospital-based endoscopy service." | 9.09 | Omeprazole therapy decreases the need for dilatation of peptic oesophageal strictures. ( Barbezat, GO; Lubcke, R; Schlup, M, 1999) |
| "To determine the efficacy of lansoprazole 30 mg given in the morning compared with high-dose ranitidine 300 mg twice daily in the treatment of patients with oesophageal strictures." | 9.08 | Prevention of recurrence of oesophageal stricture, a comparison of lansoprazole and high-dose ranitidine. ( Christian, J; Foster, CS; Garrett, AD; Gough, AL; Langworthy, CH; Swarbrick, ET, 1996) |
| "Thirty-four dysphagic patients with peptic stricture and erosive esophagitis were dilated and randomized to omeprazole 20 mg every day versus H2RA (ranitidine 150 mg twice daily or famotidine 20 mg twice daily)." | 9.07 | Omeprazole versus H2-receptor antagonists in treating patients with peptic stricture and esophagitis. ( Champion, G; Koehler, RE; Marks, RD; Mills, TP; Richter, JE; Rizzo, J; Spenney, JG, 1994) |
| "Omeprazole reduced the risk of short-term developing esophageal strictures following grade 2b and 3a corrosive esophageal injuries." | 5.41 | A prospective randomized controlled trial of omeprazole for preventing esophageal stricture in grade 2b and 3a corrosive esophageal injuries. ( Awsakulsutthi, S; Boochangkool, N; Havanond, C; Mahawongkajit, P; Mingmalairak, C; Tomtitchong, P, 2021) |
| "Effective treatment of the esophagitis and prevention of stenosis consisted in high doses of omeprazole (1." | 5.31 | High-dose omeprazole in esophagitis with stenosis after surgical treatment of esophageal atresia. ( Kerremans, I; Robberecht, E; Van Biervliet, S; Van Winckel, M, 2001) |
| " After appropriate assessment with esophageal manometry and 24 h ambulatory pHmetry, patients with documented gastroesophageal reflux disease (GERD) were treated with omeprazole continuously." | 5.12 | Single-session, graded esophageal dilation without fluoroscopy in outpatients with lower esophageal (Schatzki's) rings: a prospective, long-term follow-up study. ( Bergele, C; Mantides, A; Sgouros, SN; Stefanidis, G; Vassiliadis, K; Vlachogiannakos, J, 2007) |
| "Better control of gastric acid secretion with omeprazole appeared to decrease the need for dilatation of oesophageal strictures complicating gastro-oesophageal reflux disease in our hospital-based endoscopy service." | 5.09 | Omeprazole therapy decreases the need for dilatation of peptic oesophageal strictures. ( Barbezat, GO; Lubcke, R; Schlup, M, 1999) |
| "To determine the efficacy of lansoprazole 30 mg given in the morning compared with high-dose ranitidine 300 mg twice daily in the treatment of patients with oesophageal strictures." | 5.08 | Prevention of recurrence of oesophageal stricture, a comparison of lansoprazole and high-dose ranitidine. ( Christian, J; Foster, CS; Garrett, AD; Gough, AL; Langworthy, CH; Swarbrick, ET, 1996) |
| "In our study omeprazole was superior to either lansoprazole or pantoprazole in the maintenance treatment of complicated gastro-oesophageal reflux disease." | 5.08 | A comparison of omeprazole, lansoprazole and pantoprazole in the maintenance treatment of severe reflux oesophagitis. ( Diehl, KL; Geyer, P; Jaspersen, D; Martens, E; Schoeppner, H, 1998) |
| "Thirty-four dysphagic patients with peptic stricture and erosive esophagitis were dilated and randomized to omeprazole 20 mg every day versus H2RA (ranitidine 150 mg twice daily or famotidine 20 mg twice daily)." | 5.07 | Omeprazole versus H2-receptor antagonists in treating patients with peptic stricture and esophagitis. ( Champion, G; Koehler, RE; Marks, RD; Mills, TP; Richter, JE; Rizzo, J; Spenney, JG, 1994) |
| "The height of patients may help to predict the risks and the prescription of omeprazole may help to minimize the risks of 2b and 3a post-corrosive esophageal stricture." | 3.88 | Risk Factors for Esophageal Stricture in Grade 2b and 3a Corrosive Esophageal Injuries. ( Awsakulsutthi, S; Boochangkool, N; Havanond, C; Kanlerd, A; Limpavitayaporn, P; Mahawongkajit, P; Mingmalairak, C; Tomtitchong, P, 2018) |
| "To review the literature on the treatment of gastroesophageal reflux disease (GERD) with emphasis on pharmacological aspects." | 2.43 | Treatment of gastroesophageal reflux disease. ( Camargos, PA; Guimarães, EV; Marguet, C, 2006) |
| "Peptic esophageal strictures are a common sequelae of long-standing reflux esophagitis." | 2.38 | Peptic strictures of the esophagus. ( Marks, RD; Richter, JE, 1993) |
| "Although the key features of eosinophilic esophagitis have been increasingly described over recent years, this entity is still often not considered and consequently diagnosis is often either not made or delayed." | 1.38 | Eosinophilic esophagitis and food impaction: an instructive case. ( Day, A; Lemberg, D; Tilakaratne, S, 2012) |
| "Effective treatment of the esophagitis and prevention of stenosis consisted in high doses of omeprazole (1." | 1.31 | High-dose omeprazole in esophagitis with stenosis after surgical treatment of esophageal atresia. ( Kerremans, I; Robberecht, E; Van Biervliet, S; Van Winckel, M, 2001) |
| "Cytology from Barrett's esophagus can be misleading in the presence of severe inflammation." | 1.30 | Brush cytology in the diagnosis of neoplasia in Barrett's esophagus. ( Alderson, D; Hardwick, RH; Lott, M; Morgan, RJ; Warren, BF, 1997) |
| "Only surgery improved regurgitation." | 1.30 | The effect of medical therapy and antireflux surgery on dysphagia in patients with gastroesophageal reflux disease without esophageal stricture. ( Gadenstaetter, M; Glaser, K; Hinder, RA; Profanter, C; Wetscher, GJ, 1999) |
| "Between 1965 and 1990 200 patients were treated for peptic esophageal stricture by surgery or bougienage with antisecretory medication." | 1.29 | Peptic esophageal stricture: is surgery still necessary? ( Bischof, G; Feil, W; Riegler, M; Schiessel, R; Wenzl, E, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 23 (57.50) | 18.2507 |
| 2000's | 13 (32.50) | 29.6817 |
| 2010's | 2 (5.00) | 24.3611 |
| 2020's | 2 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mitchell, TK | 1 |
| Hall, NJ | 1 |
| Yardley, I | 1 |
| Cole, C | 1 |
| Hardy, P | 1 |
| King, A | 1 |
| Murray, D | 1 |
| Nuthall, E | 1 |
| Roehr, C | 1 |
| Stanbury, K | 1 |
| Williams, R | 1 |
| Pearce, J | 1 |
| Woolfall, K | 1 |
| Mahawongkajit, P | 2 |
| Tomtitchong, P | 2 |
| Boochangkool, N | 2 |
| Mingmalairak, C | 2 |
| Awsakulsutthi, S | 2 |
| Havanond, C | 2 |
| Limpavitayaporn, P | 1 |
| Kanlerd, A | 1 |
| Vandenplas, Y | 1 |
| Hauser, B | 1 |
| Devreker, T | 1 |
| Urbain, D | 1 |
| Reynaert, H | 1 |
| Tilakaratne, S | 1 |
| Day, A | 1 |
| Lemberg, D | 1 |
| Ward, EM | 1 |
| Achem, SR | 1 |
| Nayyar, AK | 1 |
| Royston, C | 1 |
| Bardhan, KD | 1 |
| Allakhverdian, AS | 1 |
| Mazurin, VS | 1 |
| Morozov, SV | 1 |
| Isakov, VA | 1 |
| Ibrahim, A | 1 |
| Cole, RA | 1 |
| Qureshi, WA | 1 |
| Helaly, AZ | 1 |
| Jamecci, A | 1 |
| Graham, DY | 1 |
| Ayub, K | 1 |
| Panjehpour, M | 1 |
| Overholt, BF | 1 |
| Teraishi, F | 1 |
| Fujiwara, T | 1 |
| Jikuhara, A | 1 |
| Kamitani, S | 1 |
| Morino, Y | 1 |
| Sato, K | 1 |
| Tanaka, N | 1 |
| Guimarães, EV | 1 |
| Marguet, C | 1 |
| Camargos, PA | 1 |
| Sgouros, SN | 1 |
| Vassiliadis, K | 1 |
| Bergele, C | 1 |
| Vlachogiannakos, J | 1 |
| Stefanidis, G | 1 |
| Mantides, A | 1 |
| Garg, PK | 1 |
| Sidhu, SS | 1 |
| Bhargava, DK | 1 |
| Cadiot, G | 1 |
| Hélie, C | 1 |
| Vallot, T | 1 |
| Marmuse, JP | 1 |
| Cosnes, J | 1 |
| Riché, A | 1 |
| Mignon, M | 1 |
| Marks, RD | 2 |
| Richter, JE | 2 |
| Rizzo, J | 1 |
| Koehler, RE | 1 |
| Spenney, JG | 1 |
| Mills, TP | 1 |
| Champion, G | 1 |
| Smith, PM | 1 |
| Kerr, GD | 1 |
| Cockel, R | 1 |
| Ross, BA | 1 |
| Bate, CM | 1 |
| Brown, P | 1 |
| Dronfield, MW | 1 |
| Green, JR | 1 |
| Hislop, WS | 1 |
| Theodossi, A | 1 |
| Foster, DR | 1 |
| Jaspersen, D | 5 |
| Körner, T | 2 |
| Schorr, W | 3 |
| Hammar, CH | 3 |
| Blaurock, M | 1 |
| Bischof, G | 1 |
| Feil, W | 1 |
| Riegler, M | 1 |
| Wenzl, E | 1 |
| Schiessel, R | 1 |
| Swarbrick, ET | 1 |
| Gough, AL | 1 |
| Foster, CS | 1 |
| Christian, J | 1 |
| Garrett, AD | 1 |
| Langworthy, CH | 1 |
| Silvis, SE | 1 |
| Farahmand, M | 1 |
| Johnson, JA | 1 |
| Ansel, HJ | 1 |
| Ho, SB | 1 |
| Lambert, R | 1 |
| Schwacha, H | 1 |
| Brennenstuhl, M | 1 |
| Raschka, C | 1 |
| Hardwick, RH | 1 |
| Morgan, RJ | 1 |
| Warren, BF | 1 |
| Lott, M | 1 |
| Alderson, D | 1 |
| De Peppo, F | 1 |
| Zaccara, A | 1 |
| Dall'Oglio, L | 1 |
| Federici di Abriola, G | 1 |
| Ponticelli, A | 1 |
| Marchetti, P | 1 |
| Lucchetti, MC | 1 |
| Rivosecchi, M | 1 |
| Diehl, KL | 2 |
| Schoeppner, H | 1 |
| Geyer, P | 2 |
| Martens, E | 2 |
| Arps, H | 1 |
| Borum, ML | 1 |
| Marks, ZH | 1 |
| Wetscher, GJ | 1 |
| Glaser, K | 1 |
| Gadenstaetter, M | 1 |
| Profanter, C | 1 |
| Hinder, RA | 1 |
| Barbezat, GO | 1 |
| Schlup, M | 1 |
| Lubcke, R | 1 |
| Yokohama, S | 1 |
| Ishizeki, K | 1 |
| Tamori, K | 1 |
| Inaba, M | 1 |
| Tani, M | 1 |
| Makino, I | 1 |
| Van Biervliet, S | 1 |
| Van Winckel, M | 1 |
| Robberecht, E | 1 |
| Kerremans, I | 1 |
| Chattopadhyay, A | 1 |
| Singh, S | 1 |
| Sood, A | 1 |
| Wanchu, A | 1 |
| Bambery, P | 1 |
| Sheth, NP | 1 |
| Carr, SJ | 1 |
| Wicks, AC | 1 |
| Lundell, L | 1 |
| Koop, H | 1 |
| Katschinski, M | 1 |
| Arnold, R | 1 |
5 reviews available for omeprazole and Esophageal Stricture
| Article | Year |
|---|---|
Gastric heterotopia in the proximal esophagus complicated by stricture.
Topics: Anti-Ulcer Agents; Choristoma; Dilatation; Esophageal Stenosis; Esophagoscopy; Humans; Male; Middle | 2003 |
Treatment of gastroesophageal reflux disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Adolescent; Adult; Anti-Ulcer Agents; Barre | 2006 |
Peptic strictures of the esophagus.
Topics: Behavior Therapy; Causality; Cimetidine; Diagnosis, Differential; Dilatation; Esophageal Stenosis; E | 1993 |
Esophageal stricture from idiopathic ulcers in an AIDS patient: a case report and review of the literature.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Ulcer Agents; Biopsy; Endoscopy, Digestive System; E | 1999 |
Acid suppression in the long-term treatment of peptic stricture and Barrett's oesophagus.
Topics: Barrett Esophagus; Dilatation; Esophageal Stenosis; Gastric Acid; Gastric Acidity Determination; Gas | 1992 |
12 trials available for omeprazole and Esophageal Stricture
| Article | Year |
|---|---|
A prospective randomized controlled trial of omeprazole for preventing esophageal stricture in grade 2b and 3a corrosive esophageal injuries.
Topics: Adult; Aftercare; Burns, Chemical; Caustics; Esophageal Stenosis; Humans; Omeprazole; Patient Discha | 2021 |
[Antisecretory therapy for prevention of stenoses of bougienage after-burn of esophageal strictures].
Topics: Adult; Aged; Anti-Ulcer Agents; Burns, Chemical; Esophageal Stenosis; Esophagoscopy; Esophagus; Fema | 2003 |
Schatzki's ring: to cut or break an unresolved problem.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Deglutition Disorders; Dilatation; Electrosurgery; En | 2004 |
Single-session, graded esophageal dilation without fluoroscopy in outpatients with lower esophageal (Schatzki's) rings: a prospective, long-term follow-up study.
Topics: Aged; Ambulatory Care; Deglutition Disorders; Dilatation; Enzyme Inhibitors; Esophageal Stenosis; Es | 2007 |
Role of omeprazole in prevention and treatment of postendoscopic variceal sclerotherapy esophageal complications. Double-blind randomized study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Double-Blind Method; Esophageal and Gastric Varices; Eso | 1995 |
Omeprazole versus H2-receptor antagonists in treating patients with peptic stricture and esophagitis.
Topics: Aged; Cost-Benefit Analysis; Esophageal Stenosis; Esophagitis; Female; Histamine H2 Antagonists; Hum | 1994 |
A comparison of omeprazole and ranitidine in the prevention of recurrence of benign esophageal stricture. Restore Investigator Group.
Topics: Adult; Aged; Aged, 80 and over; Chi-Square Distribution; Dilatation; Double-Blind Method; Esophageal | 1994 |
Prevention of recurrence of oesophageal stricture, a comparison of lansoprazole and high-dose ranitidine.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Dilatation; Double-Blind Method; Drug Ad | 1996 |
A randomized blinded comparison of omeprazole and ranitidine in the treatment of chronic esophageal stricture secondary to acid peptic esophagitis.
Topics: Aged; Anti-Ulcer Agents; Chi-Square Distribution; Chronic Disease; Combined Modality Therapy; Dilata | 1996 |
Omeprazole in the treatment of patients with complicated gastro-oesophageal reflux disease.
Topics: Antacids; Anti-Ulcer Agents; Dilatation; Esophageal Stenosis; Esophagitis, Peptic; Female; Follow-Up | 1996 |
A comparison of omeprazole, lansoprazole and pantoprazole in the maintenance treatment of severe reflux oesophagitis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Deglutition | 1998 |
Omeprazole therapy decreases the need for dilatation of peptic oesophageal strictures.
Topics: Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Dilatation; Enzyme Inhibitors; Esophageal Stenosi | 1999 |
23 other studies available for omeprazole and Esophageal Stricture
| Article | Year |
|---|---|
Mixed-methods feasibility study to inform a randomised controlled trial of proton pump inhibitors to reduce strictures following neonatal surgery for oesophageal atresia.
Topics: Adult; Attitude of Health Personnel; Chemoprevention; Constriction, Pathologic; Esophageal Atresia; | 2023 |
Risk Factors for Esophageal Stricture in Grade 2b and 3a Corrosive Esophageal Injuries.
Topics: Adolescent; Adult; Body Height; Burns, Chemical; Caustics; Child; Endoscopy, Gastrointestinal; Esoph | 2018 |
A biodegradable esophageal stent in the treatment of a corrosive esophageal stenosis in a child.
Topics: Absorbable Implants; Burns, Chemical; Caustics; Child; Esophageal Stenosis; Esophagitis; Esophagosco | 2009 |
Eosinophilic esophagitis and food impaction: an instructive case.
Topics: Adolescent; Androstadienes; Anti-Inflammatory Agents; Anti-Ulcer Agents; Deglutition Disorders; Drug | 2012 |
Oesophageal acid-peptic strictures in the histamine H2 receptor antagonist and proton pump inhibitor era.
Topics: Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Catheterization; Esophageal Stenosis; Female; Gas | 2003 |
Porfimer sodium photodynamic therapy for management of Barrett's esophagus with high-grade dysplasia.
Topics: Anti-Ulcer Agents; Barrett Esophagus; Catheter Ablation; Dihematoporphyrin Ether; Esophageal Neoplas | 2006 |
Esophageal intramural pseudodiverticulosis with esophageal strictures successfully treated with dilation therapy.
Topics: Aged; Antifungal Agents; Candidiasis; Catheterization; Chronic Disease; Deglutition Disorders; Diagn | 2006 |
[Stenosing esophagitis in Zollinger-Ellison syndrome].
Topics: Esophageal Stenosis; Esophagectomy; Esophagitis; Gastrectomy; Humans; Male; Middle Aged; Omeprazole; | 1994 |
Strecker esophageal stent.
Topics: Aged; Aged, 80 and over; Esophageal Stenosis; Female; Humans; Omeprazole; Stents | 1994 |
[Bouginage of peptic esophageal stenoses. Results of one year with long-term omeprazole medication].
Topics: Adult; Aged; Combined Modality Therapy; Dilatation; Esophageal Stenosis; Esophagitis, Peptic; Esopha | 1994 |
[Omeprazole in H2-receptor blockader-refractory sclerosing ulcers of the esophagus].
Topics: Esophageal and Gastric Varices; Esophageal Stenosis; Humans; Omeprazole; Polidocanol; Polyethylene G | 1993 |
Peptic esophageal stricture: is surgery still necessary?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Cimetidine; Combined Modality Therapy | 1996 |
Towards an increased efficacy of acid inhibition in the treatment of erosive oesophagitis.
Topics: Antacids; Anti-Ulcer Agents; Dilatation; Esophageal Stenosis; Esophagitis, Peptic; Histamine H2 Anta | 1996 |
Brush cytology in the diagnosis of neoplasia in Barrett's esophagus.
Topics: Adenocarcinoma; Anti-Ulcer Agents; Barrett Esophagus; Biopsy; Cell Count; Cell Nucleus; Chromatin; C | 1997 |
Stenting for caustic strictures: esophageal replacement replaced.
Topics: Anti-Bacterial Agents; Burns, Chemical; Case-Control Studies; Catheterization; Child, Preschool; Dex | 1998 |
[Benign proximal esophageal stenosis--mostly a complication of gastroesophageal reflux disease].
Topics: Anti-Ulcer Agents; Diagnosis, Differential; Dilatation; Endoscopy, Digestive System; Esophageal Sten | 1999 |
The effect of medical therapy and antireflux surgery on dysphagia in patients with gastroesophageal reflux disease without esophageal stricture.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Cisapride; | 1999 |
[Administration of proton pump inhibitor caused esophageal stenosis in two patients with severe reflux esophagitis].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Drug Administration Schedule; Esophageal Stenosis; Es | 2001 |
High-dose omeprazole in esophagitis with stenosis after surgical treatment of esophageal atresia.
Topics: Digestive System Surgical Procedures; Dose-Response Relationship, Drug; Enzyme Inhibitors; Esophagea | 2001 |
Cervical osteophyte induced dysphagia.
Topics: Anti-Ulcer Agents; Cervical Vertebrae; Cisapride; Deglutition Disorders; Esophageal Stenosis; Gastro | 2001 |
High dose Omeprazole in esophagitis with stenosis after surgical treatment of esophageal atresia.
Topics: Esophageal Atresia; Esophageal Stenosis; Esophagitis; Gastroesophageal Reflux; Humans; Omeprazole | 2002 |
Omeprazole and oesophageal stricture.
Topics: Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Dilatation; Esophageal Stenosis; Humans; | 1992 |
[Conservative treatment of florid peptic esophageal stenosis. Complete elimination by dilatation and omeprazole in H2-blocker refractory cases].
Topics: Adolescent; Adult; Aged; Combined Modality Therapy; Dilatation; Esophageal Stenosis; Esophagitis, Pe | 1991 |